EBOS Leadership Transition
| Stock | Ebos Group Ltd (EBO.ASX) |
|---|---|
| Release Time | 19 Feb 2025, 7:32 a.m. |
| Price Sensitive | Yes |
EBOS Announces Leadership Transition: John Cullity to Retire, Adam Hall Appointed as New CEO
- John Cullity to retire as CEO, effective 30 June 2025
- Adam Hall appointed as successor, effective 1 July 2025
- Adam Hall is a highly accomplished global executive with a strong track record in strategic growth, M&A, and operational excellence
EBOS Group Limited ('EBOS' or 'the Group') today announces that John Cullity will retire as Chief Executive Officer (CEO), effective 30 June 2025. EBOS is also pleased to announce that the Board has appointed Adam Hall as his successor, effective 1 July 2025. Adam Hall is a highly accomplished global executive with a strong track record in strategic growth, mergers and acquisitions, and operational excellence. Most recently, as Group Executive and President - Asia for Orica Limited, he successfully led significant growth in earnings and scale, while driving innovation and efficiency. Prior to Orica, he held senior executive roles at CF Industries and Bunge in the USA, United Kingdom and Asia. EBOS Chair, Liz Coutts, said: 'We are delighted to appoint Adam as our next CEO. Adam brings deep experience in driving operational efficiency and executing transformative M&A, having led announced transactions worth over US$20 billion in the past decade. His leadership will be instrumental as EBOS continues to pursue its growth ambitions. We look forward to working with him to continue to drive our strong growth and seize new opportunities.' 'John has been a driving force behind EBOS' success, leading the Group through significant growth. Under his leadership, EBOS has delivered total shareholder returns of 168%, significantly outperforming the market. Beyond the results, John has shaped EBOS into the company it is today -- expanding our reach, strengthening our businesses across New Zealand, Australia, and Southeast Asia, and positioning us as a leader in healthcare and animal care. On behalf of the Board, I sincerely thank John for his outstanding contribution and wish him the very best in his well-earned retirement.'
Adam Hall said: 'It's a privilege to join this exceptional team, who have driven EBOS to become a clear leader across the diverse segments in which it operates. EBOS has delivered strong and consistent performance, and I look forward to working with the Board and the Executive Leadership Team to create further growth and innovation in the years ahead.'